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Since HSV 1 can persistently infect the enteric nervous system (ENS)
causing gut dysmotility1, we investigated the role of Toll like receptor
(TLR)2 in HSV 1 induced ENS alterations.
C57/Bl6 (WT) and TLR2KO mice were inoculated with HSV 1 or
replication deficient HSVdeltaICP27 intranasally and 4 weeks (W) later
intragastrically (IG). Macrophages or CD8 lymphocytes were depleted
by clodronate liposomes or anti CD8. One 2W after viral IG injection
we determined in the ileum a) monocyte chemotactic protein 1 (MCP 1)
level by ELISA, b) infiltrating immune cells by fluorescent activated flow
cytometry, c) ENS integrity by immunohistochemistry and by changes in
isometric muscle tension following electric field stimulation.
HSV 1 or HSVdeltaICP27 IG injection in WT mice caused loss of neu-
ronal HuC/D and peripherin, altered cholinergic transmission, increased
MCP 1 and recruited activated macrophages (CD11b+F4/80+CD80+).
Clodronate mediated macrophages depletion entirely prevented HSV 1
induced ENS anomalies. TLR2KO mice failed to up regulate MCP 1 and
to recruit macrophages following HSV 1 exposure but HSV 1 reactive
CD3+CD8+INFgamma+ lymphocytes infiltrated the myenteric plexuses.
CD3+CD8+cells but notmacrophages depletion preventedHSV1 induced
ENS alterations in TLR2KO mice.
Our study provides evidences that TLR2 signaling is essential for the
optimal development of anti viral immune responses following HSV 1
infection of ENS. However, TLR2 driven recruitment of inflammatory
cells causes neuronal damage and gut dysfunction.
1. Brun, et al. Gastroenterology 201 ; 138: 1790.
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The chikungunya virus (CHIKV) and the Ross River virus (RRV), two
Alphaviruses provoke persistent myalgia/arthritis in humans. We showed
that chronic CHIKV infection in macaque (Macaca fascicularis) involved
macrophages. To better characterize the alphavirus arthritis development
mechanism in human, we compared RRV and CHIKV infections within
primate model. We infected macaques with an infectious molecular clone
of the strain LR2006 OPY 1, we previously used, and with two strains of
RRV: a) T48, a molecular clone derived from a mosquito isolate obtai-
ned in 1948 and b) QML 1, an 1999’ Australian clinical strain. We then
followed the clinical, viral and immunological parameters in peripheral
blood at different time point during the infection and on the tissues at the
euthanasia. In situ Hybridization and Immuno histochemistry allowed to
1) identify sites of viral replication and viral reservoirs tissue at the early
and late infection associated with CHIKV and RRV and viral titration
and Q PCR together with Cytokine follow up by ELISA 2) assess the
mechanisms associated with arthralgia and/or persistence of these alpha-
viruses. Our study is the first comparison of in vivo CHIKV and RRV
infections in primates, showing that despite different replication kinetic,
both pathogens are able to induce in vivo local inflammation and tissue
damage during arthralgia. Different pro inflammatory cytokines balances
showed that processes however might be distinct. Our alphaviruses chro-
nic infection model can therefore be used to assess treatment strategy for
these specific tissue damages.
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Several studies investigated miRNA expression in hepatocellular carci-
noma, but little is known on the changes in liver miRNA expression during
the different stages of chronic viral hepatitis. This study,which investigated
miRNA expression profile bymicroarray analysis in liver biopsies from 40
patients with chronic B and C viral hepatitis, identified a coherent picture
of miRNAs that were significantly associated with viral aetiology andwith
histological features of chronic liver disease. In fact, data on differentially
expressed miRNAs that were identified in this study were consistent with
validated targets and activity of eachmiRNA.AmongmodulatedmiRNAs,
the miR 200a/200b/429 cluster appeared relevant in liver disease and its
up regulation was associated with different histological markers of disease
progression (i.e., fibrosis, inflammation and necrosis, steatosis); few miR-
NAs were differentially expressed in HBV and HCV infected livers and
were conducible to specific viral activity; advanced fibrosis/cirrhosis was
associated with the overexpression of fibrosis related miRNAs, the under
expression of miRNAs with tumor suppressor activity, and with a miRNA
signature consistent with retention of the epithelial phenotype and inhibi-
tion of epithelial tomesenchymal transition. Themost significant miRNAs
associated with severe fibrosis were investigated and confirmed in amouse
model of acute liver fibrosis. In conclusion, this study described miRNAs
signatures associated with chronic viral hepatitis progression that could
be potentially used as markers of disease.
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MicroRNAs (miRNAs) regulate gene expression post transcriptionally by
altering the stability of their target mRNA. Murine gammaherpesvirus
68 (MHV 68) encodes at least 15 miRNAs derived from a cluster of
8 tRNA like molecules. The miRNAs are located in a genomic region
known to encode latency associated transcripts, but their functions are
unknown. MHV 68 naturally infects murid rodents and is closely rela-
ted to Kaposi’s sarcoma associated herpesvirus and Epstein–Barr virus
which are associated with lymphoproliferative tumours in humans. The
strict species specificity of gammaherpesviruses has limited research on
the human viruses mainly to in vitro studies. Infection of mice with MHV
68 provides a unique small animal model to investigate in vivo pathogenic
features that are difficult to assess in humans. During latency, MHV 68
expresses a protein encoded by ORF73 named murine latency associated
nuclear antigen (mLANA). In this study, a recombinant MHV 68 virus
containing beta lactamase gene fused to ORF73 was used to detect and
isolate latently infected mouse splenocytes by flow cytometry. This sys-
tem facilitates the characterisation of viral miRNAs expression in latently
infected cells. At day 14 post infectionwhich coincideswith a peak splenic
viral load, ten viral miRNAs were detected in mLANA positive spleno-
cytes with variable expression levels. In order to investigate the functions
of these miRNAs, a mutant virus that lacks the miRNAs was constructed.
The phenotypic analysis of this mutant virus will allow us to investigate
the role of viral miRNAs in pathogenesis.
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